Korean Biopharma Today And Tomorrow: M&A, Investment, Governance

Policies, Family Management In Spotlight

 
• By Jung Won Shin
  
Korea Bioplus Interphex
M&A The Biggest Keyword For Korean Biopharmas In Next Decade • Source: Jung Won Shin

More from South Korea

More from Focus On Asia